Form 8-K · Current Report · Filed 2024-02-20
Cardinal Health Completes Public Offering of Senior Notes
On February 20, 2024, Cardinal Health, Inc.
- Filer
- Cardinal Health Inc. CAH · NYSE
- Filed
- Accession
- 0001193125-24-040017
- CIK
- 0000721371
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
completed a public offering of $650,000,000 aggregate principal amount of 5.125% Notes due 2029 and $500,000,000 aggregate principal amount of 5.450% Notes due 2034. The offering was made pursuant to the Company's effective registration statement on Form S-3. The Notes were issued under an Indenture supplemented by a First Supplemental Indenture. Legal opinions regarding the issuance were provided by the Company's General Counsel and Skadden, Arps, Slate, Meagher & Flom LLP.
Items reported
Entry into a Material Definitive Agreement
Creation of a Direct Financial Obligation
Other Events
Financial Statements and Exhibits
Market reaction
Close before filing
$104.45
Next session
+1.1%
Since filing
+120.2%
Latest close
$230.03
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from CAH reporting the same item, with the next session's move:
Exhibits (4)
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Never miss another CAH filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.